DOCSLIB.ORG

How to Diagnose and Treat Haemorrhagic Skin Necrosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
How to Diagnose and Treat Haemorrhagic Skin Necrosis Clinical PRACTICE DEVELOPMENT Clinical PRACTICE DEVELOPMENT How to diagnose and treat haemorrhagic skin necrosis Haemorrhagic skin necrosis is a common manifestation of a number of different pathological processes that can evolve dramatically and carry a grave prognosis. The divergent patho-physiological basis of the condition and the many specialities involved in the initial and subsequent care of the patient means that not all patients are seen by wound care professionals. Yet such patients do present to wound healing clinics and wounds invariably develop if the affected area is large. It is therefore important that wound care experts are familiar with the common causes of haemorrhagic skin necrosis and are able to instigate the appropriate investigations and treatment. Girish K Patel coloured skin. Diagnosing the cause upon the identification of a disease that of these symptoms may be a clinically causes vessel thrombosis. KEY WORDS intimidating prospect. But when Haemorrhagic skin necrosis considering the diagnostic possibilities, Determining the cause Thrombosis it is important first to establish the of sudden thrombosis of the skin vessels Cutaneous necrosis pathological sequence of events that Rudolf Virchow worked extensively on Vasculitis have led to this presentation. the causes of thrombosis in the early 1900s and his findings still provide The process resulting in a useful framework. Virchow’s triad haemorrhagic skin necrosis begins consists of: with the sudden thrombotic occlusion 8 Alterations to blood flow he vast majority of wounds of single or multiple blood vessels (haemostasis) presenting to a wound healing supplying the skin. The compromised 8 Injury to the vascular endothelium T clinic are either post-surgical blood vessels leak red cells into the 8 Alteration in blood constituents wounds or chronic ulcers; in over 90% surrounding tissues where they become (hypercoagulability) (Malone, 2005). of cases the aetiology of the wound can trapped within the ensuing tissue be attributed to either venous disease necrosis. The subsequent deoxygenation Diseases that cause thrombosis with or without coexistent arterial of haemoglobin in the red blood typically fit into one or more of these disease, arterial disease, diabetes, cells results in the black colour of groups and each group in turn has a pressure ulceration or trauma (including the necrotic tissue. In addition, many particular pattern of skin necrosis. By surgery) (Banerjee et al, 2001; Patel cytokines are synchronously released by looking at the pattern and distribution et al, 2006). Therefore a patient dying cells and promote inflammation. At of skin necrosis it should be possible, with rapidly evolving, painful black the boundary of the necrosis the blood using Virchow’s triad, to shorten the list haemorrhagic skin necrosis is unusual vessels dilate, resulting in hyperaemia of possible diagnoses. and may be daunting for the clinician. which gives rise to the dusky grey-red This article describes the presentation, colour of the surrounding skin. Haemostasis leading to haemorrhagic skin necrosis diagnosis and management of Probably the most common example haemorrhagic skin necrosis. The necrotic tissue initially swells of microcirculation haemostasis is and later it will be sloughed off after skin necrosis resulting from pressure Haemorrhagic skin necrosis: the underlying tissue has healed with ulceration (Whitney et al, 2006). In this a diagnostic framework a scar. However, if the affected area is case the necrosis is extremely localised Patients with haemorrhagic skin sufficiently large the fibrin molecules and is characteristically centred over a necrosis may present with one or more will solidify to form an eschar that will bony prominence. painful and extremely tender black shrink as the underlying wound heals eschars surrounded by dusky grey-red (Carlson and Chen, 2007). The external pressure compresses the tissue against the underlying bone, Girish K Patel is Honorary Clinical Tutor, Department of Thus, the successful diagnosis of so that blood no longer flows effectively Dermatology, Cardiff University haemorrhagic skin necrosis depends through the tissue. There is a tendency 40 Wounds UK, 2007, Vol 3, No 4 Wounds UK, 2007, Vol 3, No 4 41 40-54Patel.indd 40 31/10/07 4:20:20 pm Clinical PRACTICE DEVELOPMENT Clinical PRACTICE DEVELOPMENT Table 2 Table 1 Factors associated with the development of pressure ulcers Factors associated with reduced blood flow that predispose to haemorrhagic skin necrosis Extrinsic factors Intrinsic factors Reduced Reduced blood flow in Moisture Systemic infection blood flow multiple vessels Friction Sensory neuropathy with or without motor neuropathy in a solitary Shear Tissue oedema vessel Malnutrition Trauma Trauma Hypotension Chilblains Chilblains Medications that interfere with healing, e.g. systemic corticosteroids Severe hypotensive shock Diabetes mellitus Drugs, e.g. sympathomimetics Atherosclerosis and ergot alkaloids Reduced consciousness Vibration white finger Incontinence Raynaud’s disease Coexistent skin diseases Berger’s disease Blood hyperviscosity, e.g. multiple myeloma to think that pressure ulceration is sites, the digits. Digital necrosis may be limited to the sacral area or hip, but a prominent feature (Figures 1 and 2). these same factors can result in ulcers The causes of this type of skin necrosis Atherosclerosis is the most over any bony prominence, including can be divided into those affecting common cause of injury to the vascular the scalp, thoracic vertebrae, elbows, a solitary vessel or those affecting endothelium and it results in blood knees and heels. Occasionally, pressure multiple vessels (Table 2). vessel occlusion from thrombosis ulcers can also develop in the absence or from emboli (Figure 3). The of a bony prominence when there are Injury to the vascular endothelium majority of arterial ulcers arise from two solid surfaces that compress the leading to haemorrhagic skin necrosis peripheral arterial disease caused by tissues between them, as has been Injury to the vascular endothelium can atherosclerosis (Weitz, 1996). Moreover observed with nasogastric tubes, blood- also lead to haemorrhagic necrosis. atherosclerosis is also involved in the pressure monitoring devices or plaster Diseases in this group can present pathogenesis of arterial aneurysms casts (Devbhandari et al, 2006). either in a localised manner, such as which can rupture, thrombose and in popliteal artery aneurysms that cause emboli that can present with The pathophysiology of pressure cause necrosis in the forefoot, or be haemorrhagic skin necrosis. While the ulceration is relatively straightforward, more widespread such as in Henoch- pathogenesis of atheroma that gives but in addition to treating the wound, Schonlein purpura. Occasionally rise to atherosclerosis is complex, management of patients with pressure the disease may be widespread as reversible risk factors associated with ulcers should address internal and in atherosclerosis, but then sudden atherosclerosis include hypertension, external exacerbating factors (Table 1) plaque rupture and thrombosis may a history of smoking, hyperlipidaemia (Reddy et al, 2006). These same factors result in a solitary localised area of and diabetes mellitus (Grey et al, 2006). can affect the extent of tissue death in skin necrosis. Thus, in addition to treating the area all forms of haemorrhagic skin necrosis associated with haemostasis and, to a lesser extent, haemorrhagic skin necrosis from other causes. When the larger vessels are affected or when there is severe hypotension, haemostasis and therefore haemorrhagic skin necrosis may affect multiple sites, often in a Figure 2. A patient with sudden onset Raynaud’s symmetrical distribution. The sites Figure 1. A patient with systemic sclerosis and disease. Skin necrosis can be a presentation of affected will be in the areas of lowest associated Raynaud’s disease, complicated by underlying malignancy. In this case, the patient had perfusion. Pressure-bearing areas will painful skin necrosis and ulceration affecting the an adenocarcinoma which is the most common type be affected as well as the most distal left distal middle finger. of malignancy with this presentation. 42 Wounds UK, 2007, Vol 3, No 4 Wounds UK, 2007, Vol 3, No 4 43 40-54Patel.indd 42 31/10/07 4:20:21 pm Clinical PRACTICE DEVELOPMENT Clinical PRACTICE DEVELOPMENT Table 3 Vasculitides associated with different types of infiltrate Haemorrhagic skin necrosis with a neutrophil rich vessel wall inflammation: Leucocytoclastic vasculitis Sweet’s syndrome Bowel associated dermatosis-arthritis syndrome Rheumatoid neutrophilic dermatosis Behcet’s syndrome Figure 5. A histological feature of leucocytoclastic Pyoderma gangrenosum vasculitis, in keeping with the clinical features Erythema elevatum diutinum Figure 4. Sudden onset of palpable purpura of the presented in figure 4, is based on the presence of lower legs can be a manifestation of small vessel transmural infiltration by neutrophils and fibrinoid Haemorrhagic skin necrosis with a lymphocyte vasculitis, as in this case. The leucocytoclastic vessel necrosis (highlighted by the arrows). rich vessel wall inflammation: vasculitis was restricted to the skin and the Often as in this case there is fragmentation of Pyoderma gangrenosum patient subsequently recovered with conservative neutrophils (leucocytoclasis) and extravasation of Leukaemic vasculitis treatment. red cells. Polymorphic light eruption Pityriasis lichenoides forms of vasculitis
Load more

Recommended publications
  • An Atypical Case of Warfarin-Induced Skin Necrosis
    CASE REPORT An Atypical Case of Warfarin-Induced Skin Necrosis Lindsay R. Sklar, MD* *Wayne State University, Department of Dermatology, Dearborn, Michigan Anne Messman, MD, FACEP† †Sinai-Grace Hospital, Department of Emergency Medicine, Detroit, Michigan Section Editor: Rick A. McPheeters, DO Submission history: Submitted December 19, 2016; Revision received March 8, 2017; Accepted March 30, 2017 Electronically published October 11, 2017 Full text available through open access at http://escholarship.org/uc/uciem_cpcem DOI: 10.5811/cpcem.2017.3.33373 Skin necrosis is a relatively rare, potentially fatal side effect of warfarin. It is most commonly reported within 10 days of initiation of therapy in warfarin-naïve patients. We report an atypical case of warfarin-induced skin necrosis upon recommencement of warfarin in a non-naïve warfarin patient. [Clin Pract Cases Emerg Med. 2017;1(4):359–361.] INTRODUCTION were significant for a normal platelet level of 180,000/mm,³ Warfarin is currently the most widely prescribed oral partial thromboplastin time of 27.7 sec, prothrombin time of anticoagulant in North America. Thrombosis is a rare, 21.8 sec, and an international normalized ratio (INR) of 1.87. paradoxical, and potentially fatal adverse effect of the drug. Computerized tomography (CT) of the abdomen with and Skin necrosis occurs secondary to the development of without intravenous contrast showed no evidence of microthrombi and endothelial cell damage in the vessels of malignancy or hemorrhage. dermal and subcutaneous tissues. Since this rare The patient had been on the same warfarin regimen (7.5mg complication was first recognized in 1943, there have been three days a week and 10mg four days a week) for two years an estimated 300 cases reported, affecting approximately prior to presentation to our ED; it had been initiated after the 0.01-0.1% of patients on the drug.1 Typically, warfarin- development of a deep vein thrombosis and pulmonary induced skin necrosis presents within three to ten days of embolism.
    [Show full text]
  • Visual Recognition of Autoimmune Connective Tissue Diseases
    Seeing the Signs: Visual Recognition of Autoimmune Connective Tissue Diseases Utah Association of Family Practitioners CME Meeting at Snowbird, UT 1:00-1:30 pm, Saturday, February 13, 2016 Snowbird/Alta Rick Sontheimer, M.D. Professor of Dermatology Univ. of Utah School of Medicine Potential Conflicts of Interest 2016 • Consultant • Paid speaker – Centocor (Remicade- – Winthrop (Sanofi) infliximab) • Plaquenil – Genentech (Raptiva- (hydroxychloroquine) efalizumab) – Amgen (etanercept-Enbrel) – Alexion (eculizumab) – Connetics/Stiefel – MediQuest • Royalties Therapeutics – Lippincott, – P&G (ChelaDerm) Williams – Celgene* & Wilkins* – Sanofi/Biogen* – Clearview Health* Partners • 3Gen – Research partner *Active within past 5 years Learning Objectives • Compare and contrast the presenting and Hallmark cutaneous manifestations of lupus erythematosus and dermatomyositis • Compare and contrast the presenting and Hallmark cutaneous manifestations of morphea and systemic sclerosis Distinguishing the Cutaneous Manifestations of LE and DM Skin involvement is 2nd most prevalent clinical manifestation of SLE and 2nd most common presenting clinical manifestation Comprehensive List of Skin Lesions Associated with LE LE-SPECIFIC LE-NONSPECIFIC Cutaneous vascular disease Acute Cutaneous LE Vasculitis Leukocytoclastic Localized ACLE Palpable purpura Urticarial vasculitis Generalized ACLE Periarteritis nodosa-like Ten-like ACLE Vasculopathy Dego's disease-like Subacute Cutaneous LE Atrophy blanche-like Periungual telangiectasia Annular Livedo reticularis
    [Show full text]
  • Energy Healing
    57618_CH03_Pass2.QXD 10/30/08 1:19 PM Page 61 © Jones and Bartlett Publishers, LLC. NOT FOR SALE OR DISTRIBUTION. CHAPTER 3 Energy Healing Our remedies oft in ourselves do lie. —WILLIAM SHAKESPEARE LEARNING OBJECTIVES 1. Describe the types of energy. 2. Explain the universal energy field (UEF). 3. Explain the human energy field (HEF). 4. Describe the seven auric layers. 5. Describe the seven chakras. 6. Define the concept of energy healing. 7. Describe various types of energy healing. INTRODUCTION For centuries, traditional healers worldwide have practiced methods of energy healing, viewing the body as a complex energy system with energy flowing through or over its surface (Rakel, 2007). Until recently, the Western world largely ignored the Eastern interpretation of humans as energy beings. However, times have changed dramatically and an exciting and promising new branch of academic inquiry and clinical research is opening in the area of energy healing (Oschman, 2000; Trivieri & Anderson, 2002). Scientists and energy therapists around the world have made discoveries that will forever alter our picture of human energetics. The National Institutes of Health (NIH) is conducting research in areas such as energy healing and prayer, and major U.S. academic institutions are conducting large clinical trials in these areas. Approaches in exploring the concepts of life force and healing energy that previously appeared to compete or conflict have now been found to support each other. Conner and Koithan (2006) note 61 57618_CH03_Pass2.QXD 10/30/08 1:19 PM Page 62 © Jones and Bartlett Publishers, LLC. NOT FOR SALE OR DISTRIBUTION. 62 CHAPTER 3 • ENERGY HEALING that “with increased recognition and federal funding for energetic healing, there is a growing body of research that supports the use of energetic healing interventions with patients” (p.
    [Show full text]
  • Purinergic Signalling in Skin
    PURINERGIC SIGNALLING IN SKIN AINA VH GREIG MA FRCS Autonomic Neuroscience Institute Royal Free and University College School of Medicine Rowland Hill Street Hampstead London NW3 2PF in the Department of Anatomy and Developmental Biology University College London Gower Street London WCIE 6BT 2002 Thesis Submitted for the Degree of Doctor of Philosophy University of London ProQuest Number: U643205 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643205 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ABSTRACT Purinergic receptors, which bind ATP, are expressed on human cutaneous kératinocytes. Previous work in rat epidermis suggested functional roles of purinergic receptors in the regulation of proliferation, differentiation and apoptosis, for example P2X5 receptors were expressed on kératinocytes undergoing proliferation and differentiation, while P2X? receptors were associated with apoptosis. In this thesis, the aim was to investigate the expression of purinergic receptors in human normal and pathological skin, where the balance between these processes is changed. A study was made of the expression of purinergic receptor subtypes in human adult and fetal skin.
    [Show full text]
  • Wound Classification
    Wound Classification Presented by Dr. Karen Zulkowski, D.N.S., RN Montana State University Welcome! Thank you for joining this webinar about how to assess and measure a wound. 2 A Little About Myself… • Associate professor at Montana State University • Executive editor of the Journal of the World Council of Enterstomal Therapists (JWCET) and WCET International Ostomy Guidelines (2014) • Editorial board member of Ostomy Wound Management and Advances in Skin and Wound Care • Legal consultant • Former NPUAP board member 3 Today We Will Talk About • How to assess a wound • How to measure a wound Please make a note of your questions. Your Quality Improvement (QI) Specialists will follow up with you after this webinar to address them. 4 Assessing and Measuring Wounds • You completed a skin assessment and found a wound. • Now you need to determine what type of wound you found. • If it is a pressure ulcer, you need to determine the stage. 5 Assessing and Measuring Wounds This is important because— • Each type of wound has a different etiology. • Treatment may be very different. However— • Not all wounds are clear cut. • The cause may be multifactoral. 6 Types of Wounds • Vascular (arterial, venous, and mixed) • Neuropathic (diabetic) • Moisture-associated dermatitis • Skin tear • Pressure ulcer 7 Mixed Etiologies Many wounds have mixed etiologies. • There may be both venous and arterial insufficiency. • There may be diabetes and pressure characteristics. 8 Moisture-Associated Skin Damage • Also called perineal dermatitis, diaper rash, incontinence-associated dermatitis (often confused with pressure ulcers) • An inflammation of the skin in the perineal area, on and between the buttocks, into the skin folds, and down the inner thighs • Scaling of the skin with papule and vesicle formation: – These may open, with “weeping” of the skin, which exacerbates skin damage.
    [Show full text]
  • 797 Circulating Tumor DNA and Circulating Tumor Cells for Cancer
    Medical Policy Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) Table of Contents • Policy: Commercial • Coding Information • Information Pertaining to All Policies • Policy: Medicare • Description • References • Authorization Information • Policy History • Endnotes Policy Number: 797 BCBSA Reference Number: 2.04.141 Related Policies Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer, #336 Policy1 Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Plasma-based comprehensive somatic genomic profiling testing (CGP) using Guardant360® for patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) is considered MEDICALLY NECESSARY when the following criteria have been met: Diagnosis: • When tissue-based CGP is infeasible (i.e., quantity not sufficient for tissue-based CGP or invasive biopsy is medically contraindicated), AND • When prior results for ALL of the following tests are not available: o EGFR single nucleotide variants (SNVs) and insertions and deletions (indels) o ALK and ROS1 rearrangements o PDL1 expression. Progression: • Patients progressing on or after chemotherapy or immunotherapy who have never been tested for EGFR SNVs and indels, and ALK and ROS1 rearrangements, and for whom tissue-based CGP is infeasible (i.e., quantity not sufficient for tissue-based CGP), OR • For patients progressing on EGFR tyrosine kinase inhibitors (TKIs). If no genetic alteration is detected by Guardant360®, or if circulating tumor DNA (ctDNA) is insufficient/not detected, tissue-based genotyping should be considered. Other plasma-based CGP tests are considered INVESTIGATIONAL. CGP and the use of circulating tumor DNA is considered INVESTIGATIONAL for all other indications. 1 The use of circulating tumor cells is considered INVESTIGATIONAL for all indications.
    [Show full text]
  • A 10 Year Cross Sectional Multicentre Study of Infected Pancreatic Necrosis
    JOP. J Pancreas (Online) 2021 Jan 30; 22(1): 11-20. ORIGINAL PAPER A 10 Year Cross Sectional Multicentre Study of Infected Pancreatic Necrosis. Trends in Management and an Analysis of Factors Predicting Mortality for Interventions in Infected Pancreatic Necrosis Johann Faizal Khan1, Suryati Mokhtar1, Krishnan Raman1, Harjit Singh1, Leow Voon Meng 2,3, Manisekar K Subramaniam1,2 1 2 Department of Hepatopancreatobiliary Surgery and Liver Transplantation, Selayang Hospital, Selangor, Malaysia 3Department of General Surgery, Division of Hepatopancreatobiliary Surgery, Sultanah Bahiyah Hospital, Kedah, Malaysia Malaysia Advanced Medical and Dental Institute (AMDI), Science University of Malaysia (USM), Penang, ABSTRACT Objective To identify trends in management and analyse outcomes of patients undergoing interventions for infected pancreatic necrosis Method A cross sectional study of patients undergoing intervention for IPN with specific reference to factors predictive of mortality. between 2009-2018 were performed at two of the largest hepatopancreatobiliary centres in Malaysia. FinalResults outcome A measuretotal number of complete of 65 resolution was compared against mortality (D). Head to head comparison of percutaneous catheter drainage alone versus Videoscopic Assisted Retroperitoneal Debridement was performed based on final predictive factor on mortality. patients with IPN were identified. Data from 59/65 patients were analysed for final outcome of death (D) versus complete resolution. 6 patients were omitted due to incomplete data
    [Show full text]
  • VII. Wound and Fracture Healing
    Journal of Rehabilitation Research and Development Rehabilitation R & D Progress Reports 1986 VII. Wound and Fracture Healing VII . Wound and Fracture Healing Electrical Stimulation for Augmentation of Wound Healing Scott R. Crowgey, M.D., and Steven M. Sharpe Veterans Administration Research and Development, Decatur, GA 30033 Sponsor: VA Rehabilitation Research and Development Service Purpose—This project will attempt to identify ing that could be influenced by electrical stimu- aspects of the wound healing process that may lation. Efforts will then be directed toward de- be augmented by the exogenous influence of veloping mathematical models of the possible electromagnetic fields. A theoretical analysis of electrical interaction of electromagnetic fields the possible effects of electromagnetic fields on with cells and cell structures to determine how wound healing will include analyses of the these interactions could be optimized to im- interaction of electromagnetic fields with cellu- prove wound healing. It is anticipated that the lar structures and of the deposition of heat in literature will not contain all the information damaged tissue via exogenously applied energy necessary to develop these models . Any gaps in fields. This analysis will then be used as a basis necessary information and data will be filled, if for developing a plan for future investigations practical, using tissue phantom modeling mate- into the potential application of electrical stim- rials, blood, and possibly even primitive tissue ulation for the augmentation of wound healing. culture exposed to a variety of known electro- The initial research will involve a review of magnetic environments, using easily construct- the literature to identify aspects of wound heal- ed exposure chambers.
    [Show full text]
  • Wound Care: the Basics
    Wound Care: The Basics Suzann Williams-Rosenthal, RN, MSN, WOC, GNP Norma Branham, RN, MSN, WOC, GNP University of Virginia May, 2010 What Type of Wound is it? How long has it been there? Acute-generally heal in a couple weeks, but can become chronic: Surgical Trauma Chronic -do not heal by normal repair process-takes weeks to months: Vascular-venous stasis, arterial ulcers Pressure ulcers Diabetic foot ulcers (neuropathic) Chronic Wounds Pressure Ulcer Staging Where is it? Where is it located? Use anatomical location-heel, ankle, sacrum, coccyx, etc. Measurements-in centimeters Length X Width X Depth • Length = greatest length (head to toe) • Width = greatest width (side to side) • Depth = measure by marking the depth with a Q- Tip and then hold to a ruler Wound Characteristics: Describe by percentage of each type of tissue: Granulation tissue: • red, cobblestone appearance (healing, filling in) Necrotic: • Slough-yellow, tan dead tissue (devitalized) • Eschar-black/brown necrotic tissue, can be hard or soft Evaluating additional tissue damage: Undermining Separation of tissue from the surface under the edge of the wound • Describe by clock face with patients head at 12 (“undermining is 1 cm from 12 to 4 o’clock”) Tunneling Channel that runs from the wound edge through to other tissue • “tunneling at 9 o’clock, measuring 3 cm long” Wound Drainage and Odor Exudate Fluid from wound • Document the amount, type and odor • Light, moderate, heavy • Drainage can be clear, sanguineous (bloody), serosanguineous (blood-tinged),
    [Show full text]
  • SOCH111 History of Healing Last Modified: 17-Jun-2021
    SUBJECT OUTLINE Subject Name: Subject Code: History of Healing SOCH111 SECTION 1 – GENERAL INFORMATION Award/s: Total Course Credit Points: Level: Bachelor of Health Science (Naturopathy) 128 1st Year Bachelor of Health Science (Myotherapy) 96 1st Year Bachelor of Health Science (Nutritional and Dietetic Medicine) 96 1st Year Bachelor of Complementary Medicine 48 1st Year Diploma of Health Science 32 1st Year Duration: 1 Semester Subject is: Core Subject Credit Points: 4 Student Workload: No. timetabled hours per week: No. personal study hours per week: Total hours per week: 6 4 10 Delivery Mode*: ☐ On campus ☒ Online / Digital ☐ Blended ☐ Intensive Weekly Session^ Format/s - 2 sessions per week: ☒ eLearning modules: Lectures: Interactive adaptive online learning modules Tutorials: can include asynchronous tutor moderated discussion forum and activities, learning journal activities or other web-based resources *All modes are supported by the online learning management system which will include subject documents such as handouts, readings and assessment guides. ^A ‘session’ is made up of 3 hours of timetabled / online study time per week unless otherwise specified. Each subject has a set number of sessions as outlined above. Study Pattern: ☒ Full Time ☒ Part Time Pre-requisites: Nil Co-requisites: Nil SECTION 2 – ACADEMIC DETAILS Subject Rationale This subject provides the student with an understanding of the history and philosophy underpinning traditional and other whole medical systems from early human existence to the present day in diverse cultures worldwide. Social, Australian College of Natural Medicine Pty Ltd trading as Endeavour College of Natural Health, FIAFitnation (National CRICOS #00231G, RTO #31489) SOCH111 History of Healing Last modified: 17-Jun-2021 Version: 27.0 Page 1 of 10 cultural and political developments are considered in the evolution of healing and medicine, as well as the parallel developments in anatomy, physiology and other sciences.
    [Show full text]
  • Suturing with U-Technique Versus Un
    Official Title of the Study: Suturing with U-Technique versus Un- Reapproximated wound Edges during removal of Closed Thoracostomy-tube drain - A single centre Open-label randomized prospective trial (SUTURE TRIAL) NCT NUMBER: Not Yet Assigned DATE OF DOCUMENT: January 16, 2019 1 STUDY SUMMARY Title: Suturing with U-Technique versus Un-Reapproximated wound Edges during removal of Closed Thoracostomy-tube drain - A single centre Open-label randomized prospective trial (SUTURE TRIAL) Background: Closed thoracostomy tube drainage or chest tube insertion is one of the most commonly performed procedures in thoracic surgery. There are several published evidence-based guidelines on safe performance of a chest tube insertion. However, there is absence of prospective controlled trials or systematic reviews indicating the safest technique of closing the wound created at the time of chest tube insertion and that best guarantees good wound and overall outcomes, post-chest tube removal. The use of a horizontal mattress non-absorbable suture or U- suture which is placed at the time of chest tube insertion and used to create a purse-string wound re-approximation at the time of tube removal has been an age-long and time-honored practice in most thoracic surgical settings. It has been established by a recent study that an occlusive adhesive-absorbent dressing can also be safely used to occlude the wound at the time of chest tube removal with good wound and overall outcomes though the study focused on tubes inserted during thoracic surgical operations.
    [Show full text]
  • WA Coding Rule 1215/07 Skin Ulcer Necrosis Versus Gangrene
    WA Coding Rules are a requirement of the Clinical Coding Policy MP0056/17 Western Australian Coding Rule 1215/07 Skin ulcer necrosis versus gangrene WA Coding Rule 0110/06 Skin ulcer necrosis versus gangrene is superseded by ACCD Coding Rule Skin necrosis (Ref No: Q2659) effective 1 January 2014; (log in to view on the ACCD CLIP portal). DECISION WA Coding Rule 0110/06 Skin ulcer necrosis versus gangrene is retired. [Effective 01 Jan 2014, ICD-10-AM/ACHI/ACS 8th Ed.] Page 1 of 3 © Department of Health WA 2018 WA Coding Rules are a requirement of the Clinical Coding Policy MP0056/17 Western Australian Coding Rule 0110/06 Skin ulcer necrosis versus gangrene Q. Often with traumatic wounds or infection there will be documentation of devitalized tissue or necrotic wound edges or just some mention of necrotic tissue, the extent of the necrosis usually not known. No mention of gangrene. The ICD 10 indexing for necrosis defaults to coding R02. For cases with documentation of necrosis irrespective of the extent of necrosis and definitely no mention of gangrene is the coder to assign the code R02 or if documentation suggests the amount of necrosis is small and confined to edges should this be considered part of the traumatic wound and the code not assigned? Necrosis is commonly documented in the patient records with traumatic wounds, burns, pressure sores etc. Necrosis due to lack of oxygen such as with a MI would be considered part of the MI code as would any necrosis with infection in pneumonia. Gangrene would seem to be a complication of necrotic tissue.
    [Show full text]